Deep Brain Stimulation Devices Market Size, Share, Report 2021-2030

The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by 2030 and it is estimated to expand at a CAGR of 5.1% from 2021 to 2030.

Telehealth and eHealth apps are gaining popularity during the ongoing coronavirus pandemic to routinely monitor PD patients. Favorable reimbursement policies across healthcare facilities worldwide are contributing to the expansion of the deep brain stimulation devices market for Parkinson’s disease. However, there is a need for technological advancements in implantable pulse generators of DBS systems. Hence, companies in the deep brain stimulation devices market for Parkinson’s disease should increase R&D for maximizing battery longevity, combined with patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff. Device-specific features such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch are crucial for med-tech companies to gain a competitive edge in the global deep brain stimulation devices market for Parkinson’s disease.

Get the sample copy of report@ https://qyresearchmedical.com/sample/112073

Commercialization of Portable, Affordable, and Effective DBS Devices

Companies operating in the deep brain stimulation devices market for Parkinson’s disease are increasing efforts to commercialize devices in the global market. Products of other companies active in the market for DBS (deep brain stimulation) are not yet commercially available, as these are still under clinical trial. Companies are keen on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.

Telehealth Helps Address Challenges of PD Patients amid Coronavirus Pandemic

The containment measures taken by various government authorities during the ongoing coronavirus pandemic has caused the interruption of neurological activities for outpatient clinics. Vulnerable patients suffering from Parkinson’s disease (PD) and dystonic patients with deep brain stimulation may have an increased risk of chronic stress related to social restriction measures and show a potential worsening of motor & psychiatric symptoms. In such cases, telehealth and eHealth mobile apps are playing a key role to address the symptoms of PD patients. Moreover, med-tech companies are increasing efforts to maintain robust supply of DBS devices to prevent interruptions in medical treatment of patients.

DBS Surgical Therapy V/S Drug Therapy: Which is Better?

According to analysts at Transparency Market Research (TMR), the growing popularity of minimally invasive procedures is estimated to drive the demand for deep brain stimulation devices for Parkinson’s disease. The deep brain stimulation surgical therapy is currently gaining traction and has risen to a popular therapy of choice when the Parkinson’s disease in the patient is at its advanced stage.

Since the drug therapy is associated with certain adverse events, doctors, and patients are increasingly opting for deep brain stimulation surgical therapies. In addition, the efficacy of drug therapy cannot be determined in terms of certainty. This is another factor, which is driving doctors and patients to choose the deep brain stimulation surgical therapy over drug therapy.

View Full Report with complete report ToC@ https://qyresearchmedical.com/report/deep-brain-stimulation-devices-market-for-parkinsons-disease-product-type-single-channel-deep-brain-stimulator-and-dual-channel-deep-brain-stimulator-and-end-user-hospitals-ambulatory-surgical-centers-neuro-2021-2030/112073

Popularity of DBS Devices for Surgical Procedures in America Benefits Med-tech Companies

The global deep brain stimulation devices market for Parkinson’s disease is positioned to register a modest CAGR throughout the forecast period. North America is predicted to dictate the global market during the forecast period, accounting for more than 30% to 40% share by 2030. The market in the region is anticipated to reach a significant value growth by 2030.

North America’s largest market share can be attributed to increase in a number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and surge in geriatric population. Additionally, favorable government reimbursement policies and risk of side effects related to medication treatments are expected to boost the growth of the deep brain stimulation devices market for Parkinson’s disease in the region.

Increase in Number of Medical Practitioners Adopting Deep Brain Stimulation Devices

Burgeoning growth of the geriatric population and rise in demand for minimally invasive surgical techniques are triggering the growth of the deep brain stimulation devices market for Parkinson’s disease. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global deep brain stimulation devices market for Parkinson’s disease in the upcoming decade. This is due to considerable side effects and loss of effectiveness of drugs & other therapeutics. This is anticipated to drive the market for DBS devices over the next few years.

Risk of Infection with IPG Affects Acceptance for DBS Devices

The global market for DBS devices is predicted to register favorable Y-o-Y growth throughout the assessment period. However, there are a few factors, which are anticipated to go against the growth of the market. One of the key factors hampering the growth of this market is the associated risks involved with deep brain stimulation procedures.

For instance, implantable pulse generator (IPG) is the core power supply and programmable element in DBS systems. However, the risk of infections due to IPG is expected to limit the use of deep brain stimulation devices for Parkinson’s disease. Hence, healthcare stakeholders should increase awareness about antibiotic impregnation and co-administration & other surgical considerations during IPG implantation such as the use of tack-up sutures & smaller profile devices.

Deep Brain Stimulation Devices Market for Parkinson’s Disease: Overview

Parkinson’s disease is one of the most common chronic and progressive neurological disorders, which is characterized by postural instability, bradykinesia, akinesia, and tremors due to loss of dopamine producing neurons in substantianigra of the mid-brain

Increase in Government Initiatives: Key Driver

Increase in number of neurological disorders such ischemic stroke, Alzheimer’s disease, tremors, trauma, and Parkinson’s disease (PD) are primary factors responsible for the growth of the global deep brain stimulation devices market

Additionally, surge in the geriatric population and rise in demand for minimally invasive surgical techniques boost the growth of the global market. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the growth of the global deep brain stimulation devices market in the near future. This can be attributed to considerable number of side effects and loss of effectiveness of drug and other therapies.

North America to Dominate Deep Brain Stimulation Devices Market for Parkinson’s Disease

Based on product type, the global deep brain stimulation devices market for Parkinson’s disease has been segmented into single-channel deep brain stimulator, and dual-channel deep brain stimulator

In terms of end-user, the global deep brain stimulation devices market for Parkinson’s disease has been classified into hospitals, ambulatory surgical centers, neurological clinics, and others

In terms of region, the global deep brain stimulation devices market for Parkinson’s disease has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America is projected to dominate the global market during the forecast period, accounting for 38.60% share by 2030. The market in the region is anticipated to reach US$ 0.48 Bn by 2030.

North America’s largest market share can be attributed to increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and surge in the geriatric population. Additionally, favorable government reimbursement policies and risk of side effects related to medication treatments are expected to boost the growth of the market in North America.

Small market share of Asia Pacific, Latin America, and Middle East & Africa can be ascribed to lack of awareness, lack of favorable government support & other insurance policies, and high cost of these devices

Major Players

Major players operating in the global deep brain stimulation devices market are Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation. These companies have commercialized several significant DBS devices in the global market such as Libra, Activa, and Vercise. Other companies that are prominently active in the market are AlevaNeurotherapeutics SA, Adaptive Neuromodulation GmbH (ANM), NeuroSigma, Inc., and NeuroPace, Inc. DBS products of these players are not yet commercially available in the market, as these are still under clinical trials.

Companies focus on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.

Each of these players has been profiled in the deep brain stimulation devices market for Parkinson’s disease report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Key Questions Answered in Deep Brain Stimulation Devices Market for Parkinson’s Disease Report

• What will be the sales revenue generated by each country of the market across all regions during the forecast period?
• What are the key trends in the global deep brain stimulation devices market for Parkinson’s disease?
• What are major drivers, restraints, and opportunities in the global deep brain stimulation devices market for Parkinson’s disease?
• The market in which region is likely to expand at a high CAGR during the forecast period?
• Which segment of the global deep brain stimulation devices market for Parkinson’s disease will generate the maximum revenue by 2028? Which product segment will expand at the fastest CAGR during the forecast period?

Deep Brain Stimulation Devices Market for Parkinson’s Disease – Segmentation

Product Type

• Single-channel Deep Brain Stimulator
• Dual-channel Deep Brain Stimulator

End-user

• Hospitals
• Ambulatory Surgical Centers

• Neurological Clinics
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112073/

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi